A cross-sectional and longitudinal analysis examined the distribution of people by obesity level using the European ...

The most prevalent complications among newly identified people with obesity were hypertension, arthritis, diabetes, and ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss ...

A recent study reveals that nearly 20% of Indian households have all adults classified as overweight, while 10% are obese. States like Manipur and Kerala show over 30% of households with all ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

Conclusions Once-weekly cagrilintide–semaglutide (at a dose of 2.4 mg each) resulted in a significantly lower body weight than placebo in adults with obesity and type 2 diabetes.

Conclusions Cagrilintide–semaglutide provided significant and clinically relevant body-weight reductions in adults with overweight or obesity, as compared with placebo.

About a million people in England are putting themselves at risk of dying early because they are overweight and combine ...

Studies suggest that artichoke extract can help lower cholesterol and blood pressure, reduce liver inflammation, and aid with ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.